Strategic Wealth Partners, Ltd. Astrazeneca PLC Transaction History

Strategic Wealth Partners, Ltd.

$1.19 Billion
Q3 2025

A detailed history of Strategic Wealth Partners, Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Strategic Wealth Partners, Ltd. holds 181,216 shares of AZN stock, worth $16.2 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

181,216

Previous 169,881 6.67%

Holding current value

$16.2 Million

Previous $11.9 Million 17.11%

% of portfolio

1.17%

Previous 1.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$68.72 - $82.11 $778,941 - $930,716	11,335 Added 6.67%	181,216 $13.9 Million
Q2 2025 Aug 11, 2025	BUY	$64.87 - $75.0 $709,418 - $820,200	10,936 Added 6.88%	169,881 $11.9 Million
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $3.87 Million - $4.87 Million	61,259 Added 62.71%	158,945 $10.4 Million
Q3 2024 Oct 08, 2024	BUY	$76.67 - $87.62 $330,677 - $377,905	4,313 Added 4.62%	97,686 $7.61 Million
Q2 2024 Oct 08, 2024	BUY	$66.81 - $80.83 $277,795 - $336,091	4,158 Added 4.66%	93,373 $7.28 Million

Q1 2024 May 20, 2024	BUY	$61.03 - $69.57 $560,316 - $638,722	9,181 Added 11.47%	89,215 $6.04 Million
Q4 2023 May 20, 2024	BUY	$61.89 - $69.28 $1.4 Million - $1.57 Million	22,700 Added 39.59%	80,034 $5.39 Million
Q3 2023 May 20, 2024	BUY	$64.85 - $71.7 $1.45 Million - $1.6 Million	22,373 Added 63.99%	57,334 $3.88 Million
Q2 2023 May 20, 2024	SELL	$69.91 - $75.81 $11,954 - $12,963	-171 Reduced 0.49%	34,961 $2.5 Million
Q1 2023 Apr 24, 2023	BUY	$63.15 - $71.6 $152,949 - $173,415	2,422 Added 7.4%	35,132 $2.44 Million
Q4 2022 Apr 24, 2023	BUY	$54.21 - $70.44 $557,712 - $724,686	10,288 Added 45.88%	32,710 $2.22 Million
Q3 2022 Apr 24, 2023	BUY	$53.02 - $135.75 $75,182 - $192,493	1,418 Added 6.75%	22,422 $1.23 Million
Q2 2022 Aug 22, 2022	BUY	$59.26 - $71.14 $93,334 - $112,045	1,575 Added 8.11%	21,004 $1.39 Million
Q1 2022 May 19, 2022	BUY	$55.72 - $67.12 $166,101 - $200,084	2,981 Added 18.12%	19,429 $1.29 Million
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $277,068 - $327,384	5,129 Added 45.31%	16,448 $958,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $7,500 - $8,206	135 Added 1.21%	11,319 $680,000
Q2 2021 Aug 25, 2021	BUY	$48.42 - $60.18 $8,425 - $10,471	174 Added 1.58%	11,184 $670,000
Q1 2021 May 24, 2021	BUY	$47.16 - $54.44 $519,231 - $599,384	11,010 New	11,010 $547,000
Q2 2019 Aug 06, 2019	SELL	$37.28 - $41.68 $4,361 - $4,876	-117 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $4,152 - $5,033	117 New	117 $5,000
Q2 2018 Sep 04, 2018	SELL	$34.55 - $37.05 $14,752 - $15,820	-427 Closed	0 $0
Q1 2018 Jul 13, 2018	BUY	$32.97 - $36.63 $14,078 - $15,641	427 New	427 $15,000

Others Institutions Holding AZN

# of Institutions

1,499

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.

Account

Strategic Wealth Partners, Ltd. Astrazeneca PLC Transaction History